JOSE RIVERA: Open Payments
NPI 1003937194 · CUDAHY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,792 in 80 payments from 24 companies in 2025. Trend: 2023 $1,537 · 2024 $1,394 · 2025 $1,792
Food & beverage: $1,782Education: $10
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $180 |
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| Sumitomo Pharma America, Inc. | 7 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $142 |
| Novo Nordisk Inc | 6 | $139 |
| Lilly USA, LLC | 5 | $126 |
| Eisai Inc. | 4 | $125 |
| SANOFI-AVENTIS U.S. LLC | 3 | $111 |
| Lundbeck LLC | 6 | $109 |
| Dexcom, Inc. | 4 | $102 |
Products named: REXULTI, GEMTESA, JARDIANCE, KRYSTEXXA, MOUNJARO, Leqembi, TZIELD, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
